Glenmark Life Sciences announces death of independent director

Glenmark Life Sciences (BSE: GLS) has announced the death of its Independent Director, Mr. Vijaykumar Ratilal Shah (DIN: 00376570), effective February 26, 2025. Shah had been serving as an Independent Director since his appointment on March 6, 2024. The company conveyed that his passing represents an irreparable loss, and the board and employees have extended their condolences to his family. Further, the announcement notes that Shah's roles as the Chairman of the Risk Management Committee and member of the Stakeholder's Relationship Committee and Corporate Social Responsibility Committee have ceased. Glenmark Life Sciences has affirmed that details pursuant to the SEBI Listing Regulations are annexed to the filing.